"hypoproliferative" meaning in All languages combined

{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "hypo",
        "3": "proliferative"
      },
      "expansion": "hypo- + proliferative",
      "name": "prefix"
    }
  ],
  "etymology_text": "From hypo- + proliferative.",
  "head_templates": [
    {
      "args": {
        "1": "-"
      },
      "expansion": "hypoproliferative (not comparable)",
      "name": "en-adj"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "adj",
  "senses": [
    {
      "categories": [
        {
          "kind": "other",
          "name": "English entries with incorrect language header",
          "parents": [
            "Entries with incorrect language header",
            "Entry maintenance"
          ],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "English terms prefixed with hypo-",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "Pages with 1 entry",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "Pages with entries",
          "parents": [],
          "source": "w"
        }
      ],
      "examples": [
        {
          "ref": "2015, Bernhard Ziegler et al., “Thromboelastometric Monitoring of the Hemostatic Effect of Platelet Concentrates Transfusion in Thrombocytopenic Children Undergoing Chemotherapy”, in Clinical and Applied Thrombosis/Hemostasis, volume 21, →DOI:",
          "text": "Current guidelines recommend a threshold of 10 × 10 9 /L for prophylactic platelet transfusion and as suitable in patients without additional risk factors (eg, sepsis, concurrent use of antibiotics, and other abnormalities of hemostasis). 21, 22 In a trial investigating the efficacy and safety of therapeutic versus prophylactic platelet transfusion to prevent bleeding in patients with hypoproliferative thrombocytopenia, the authors recommended that in patients with acute myeloid leukemia prophylactic platelet administration should remain the standard of care. 23 A similar threshold of 10 × 10 9 /L was recommended by the American Society of Clinical Oncology in their clinical practice guidelines for platelet transfusion in patients with cancer. 1 This recommendation was made for adult patients receiving therapy for acute leukemia, and patients with solid tumors during chemotherapy-induced thrombocytopenia.",
          "type": "quote"
        }
      ],
      "glosses": [
        "Less than normally proliferative"
      ],
      "id": "en-hypoproliferative-en-adj-d~rKnz1D",
      "links": [
        [
          "proliferative",
          "proliferative"
        ]
      ],
      "related": [
        {
          "word": "hypoproliferation"
        }
      ],
      "tags": [
        "not-comparable"
      ]
    }
  ],
  "word": "hypoproliferative"
}

{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "hypo",
        "3": "proliferative"
      },
      "expansion": "hypo- + proliferative",
      "name": "prefix"
    }
  ],
  "etymology_text": "From hypo- + proliferative.",
  "head_templates": [
    {
      "args": {
        "1": "-"
      },
      "expansion": "hypoproliferative (not comparable)",
      "name": "en-adj"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "adj",
  "related": [
    {
      "word": "hypoproliferation"
    }
  ],
  "senses": [
    {
      "categories": [
        "English adjectives",
        "English entries with incorrect language header",
        "English lemmas",
        "English terms prefixed with hypo-",
        "English terms with quotations",
        "English uncomparable adjectives",
        "Pages with 1 entry",
        "Pages with entries"
      ],
      "examples": [
        {
          "ref": "2015, Bernhard Ziegler et al., “Thromboelastometric Monitoring of the Hemostatic Effect of Platelet Concentrates Transfusion in Thrombocytopenic Children Undergoing Chemotherapy”, in Clinical and Applied Thrombosis/Hemostasis, volume 21, →DOI:",
          "text": "Current guidelines recommend a threshold of 10 × 10 9 /L for prophylactic platelet transfusion and as suitable in patients without additional risk factors (eg, sepsis, concurrent use of antibiotics, and other abnormalities of hemostasis). 21, 22 In a trial investigating the efficacy and safety of therapeutic versus prophylactic platelet transfusion to prevent bleeding in patients with hypoproliferative thrombocytopenia, the authors recommended that in patients with acute myeloid leukemia prophylactic platelet administration should remain the standard of care. 23 A similar threshold of 10 × 10 9 /L was recommended by the American Society of Clinical Oncology in their clinical practice guidelines for platelet transfusion in patients with cancer. 1 This recommendation was made for adult patients receiving therapy for acute leukemia, and patients with solid tumors during chemotherapy-induced thrombocytopenia.",
          "type": "quote"
        }
      ],
      "glosses": [
        "Less than normally proliferative"
      ],
      "links": [
        [
          "proliferative",
          "proliferative"
        ]
      ],
      "tags": [
        "not-comparable"
      ]
    }
  ],
  "word": "hypoproliferative"
}